ArticleCureus2025
The Challenges of Approaching a Giant Breast Mass: A Case Report With Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The classical clinical approach to any breast lesion is through the triple assessment: clinical, radiological, and pathological. However, with giant breast masses, the classical assessment might have limitations in revealing the diagnosis. We report a case of a rapidly growing left breast mass in a 60-year-old woman. In a short period of time, the lesion reached a giant size of 48 cm x 43 cm with mixed constructure and skin changes. The lesion was considered malignant by triple assessment, but the core needle biopsy could not reach a single pathological diagnosis. Giant breast masses are a rare entity of breast lesions that include different benign and malignant diseases. These diseases include malignant forms of breast sarcomas, phyllodes, and leiomyosarcomas, which are aggressive diseases requiring combative management. Diagnosing a giant breast tumor is challenging and demands a high level of suspicion. The classical approach may fail, raising the need for a special approach for such lesions. The adjusted guidelines may involve early multidisciplinary team involvement, advanced imaging, precise biopsy techniques, and earlier neoadjuvant therapy planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.